نتایج جستجو برای: biologic markers

تعداد نتایج: 278893  

2008
K. S. Courneya C. M. Booth S. Gill P. O ’ Brien J. Vardy C. M. Friedenreich H. J. Au D. Tu H. Dhillon R. M. Meyer

Trial participants (n = 962) will be stratified by centre, disease stage, body mass index, and performance status, and will be randomly assigned to a structured PA intervention or to general health education materials. The PA intervention will consist of a behavioural support program and supervised PA sessions delivered over a 3-year period, beginning with regular face-to-face sessions and tape...

Journal: :Environmental Health Perspectives 2004
Mark Toraason Richard Albertini Steven Bayard William Bigbee Aaron Blair Paolo Boffetta Stefano Bonassi Steven Chanock David Christiani David Eastmond Samuel Hanash Carol Henry Fred Kadlubar Frank Mirer Daniel Nebert Stephen Rapport Kathleen Rest Nathaniel Rothman Avima Ruder Russell Savage Paul Schulte Jack Siemiatycki Peter Shields Martyn Smith Paige Tolbert Roel Vermeulen Paolo Vineis Sholom Wacholder Elizabeth Ward Michael Waters Ainsley Weston

As high-throughput technologies in genomics, transcriptomics, and proteomics evolve, questions arise about their use in the assessment of occupational cancers. To address these questions, the National Institute for Occupational Safety and Health, the National Cancer Institute, the National Institute of Environmental Health Sciences, and the American Chemistry Council sponsored a workshop 8-9 Ma...

2016
Tara F. Carr Eugene Bleecker

Asthma is a common, chronic inflammatory airways disease characterized by a clinical syndrome of bronchial hyperresponsiveness, inflammation, and reversible airflow obstruction. Individuals with asthma can vary widely in clinical presentation, severity, and pathobiology. The incident factors, pathogenesis, prognosis, and treatment of asthma remain incompletely understood. Utilizing measurable c...

Journal: :Skin 2023

Introduction: Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, is approved by the US FDA for treatment of adults with moderate-to-severe plaque psoriasis who are candidates systemic therapy or phototherapy. Deucravacitinib was significantly more efficacious than placebo apremilast and well tolerated in previous reports from phase 3 POETYK PSO-1 trial. Here, we examin...

Journal: :Clinical chemistry 2008
Diane J Catellier Nena Aleksic Aaron R Folsom Eric Boerwinkle

BACKGROUND Cellular markers help identify different components of a pathological process and may contribute to the diagnosis, prognostic assessment, and management of patients with suspected syndromes. Flow cytometry can be used to accurately assess markers of platelet and leukocyte activation and cellular aggregation in whole blood. To use cell markers as predictors of disease requires that th...

پایان نامه :دانشگاه آزاد اسلامی - دانشگاه آزاد اسلامی واحد تهران مرکزی - دانشکده زبانهای خارجی 1391

different researchers in different parts of the world have investigated the strategies used to translate written works ranging from novels to classroom assignments. however, by the significant increase in the number of postgraduate students in iran in the last few years, a very common kind of translation in iran includes translating abstracts of master’s theses. in this work, the researcher hav...

Journal: :Oncology 2006
Ronald M Bukowski

This report of a case of cytokine-refractory metastatic, clear-cell renal cell carcinoma (RCC) presents some current issues related to use of targeted therapy in the community. Due to the different mechanisms of cytostatic vs. cytotoxic agents, traditional response assessments may not always apply in deciding when to either continue or stop treatment. While community physicians may increasingly...

Journal: :Blood 1990
C W Taylor T M Grogan S E Salmon

Recombinant human interleukin-4 (rhIL-4) has pleiotropic biologic effects including stimulation of normal B-cell growth. We investigated the effects of rhIL-4 on the in vitro growth of 35 fresh human lymphoid and plasma cell malignancies. Inhibition of growth was seen in 52% and 60% of multiple myeloma and lymphoma specimens, respectively. Growth was stimulated relative to control in 8.6% (3 of...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید